new measures of the Government restricted patient access to medications
-the new RDL is a profound change in the pharmaceutical provision negatively affecting both the sector and citizens
-the Government rejects, once again, the involvement of Parliament and of the representative institutions of the sector to introduce modifications by way of the RDL
– aims to increase the dispensación in hospitals as a means of saving, when it actually means not known nor controlled spending and a high cost in interest on arrears
-the new concept of selected price ” gives legal cover to the Andalusian bidding system, being excluded not selected drugs of pharmaceutical delivery
Madrid, August of 2011- new Royal Decree Law of measures for the improvement of the quality and cohesion of the National health system, approved last Friday by the Council of Ministers, restricts access for all patients to drugs. Exact prescription for active principle, forcing to dispense the medicine of lower prices in all categories, will affect the patient when go to the pharmacy to pick up your prescriptions.
For the Business Federation of Spanish pharmaceutical (FEFE), measures adopted by the Government considerably decrease the level of benefits to users, pose much less than the announced expenditure savings, introduce new categories that will require legislative developments to verify their usefulness, and do not represent any improvement in the quality and consistency of the SNS.
New Royal Decree-Law introduces important modifications in the law of guarantees, law of recent publication approved by this same Government, constituting a profound change in the pharmaceutical provision will affect negatively both operators in the sector and the citizens. Addition, to again use the path of Royal Legislative Decree to introduce its amendments the Government prevents the involvement of Parliament and representative of the sector institutions.
Revising the wording of the said Royal Decree-Law, it attaches to the Government the establishment of unique reserves ” by economic criteria. Moreover, it aims to increase the dispensing in hospitals as a means of savings, quality and cohesion when, in reality, this is an expense or controlled known only is a disorder for patients, having to scroll long distances and expect long queues to obtain their medications, and represents a high cost in interest on arrears.
On the other hand, the new concept of selected price ” gives legal cover to the Andalusian bidding system, being excluded not selected drugs of pharmaceutical delivery.
All changes included in this text will be made by resolution of the General Directorate of pharmacy, which means that there will be no period of allegations and parties only have compared its application resource Alpine.